Cerebral palsy is a common motor dysfunction disease in children. Research on umbilical cord blood stem cell treatment for pediatric cerebral palsy has made positive progress, bringing new hope to affected families.
Research overview
The study included young children with autologous umbilical cord blood cryopreserved after birth, and stem cells were infused back through intravenous infusion and other methods, with good safety. Umbilical cord blood is rich in hematopoietic stem cells and various active factors, which may improve neurological function through mechanisms such as neural nutrition and immune regulation.
Efficacy observation
Motor improvement usually accumulates over several months after the course of treatment with rehabilitation, and early intervention and continuous rehabilitation training help consolidate results.
Significance for international families
Overseas families can submit the child's medical history and imaging through remote consultation to evaluate treatment suitability. MedBridge assists in arranging multidisciplinary evaluation and treatment itineraries at partner hospitals.
MedBridge services
MedBridge provides international pediatric patient families with medical record translation, expert booking, visit accompaniment and follow-up support, making cross-border medical treatment more reassuring.